French-American Biotech & BIO BIZ Symposiums (FABS & FABZ) on “New therapeutical and vaccine approaches in infectious diseases” – April 2nd & 3rd 2008

Home » Events News » French-American Biotech & BIO BIZ Symposiums (FABS & FABZ) on “New therapeutical and vaccine approaches in infectious diseases” – April 2nd & 3rd 2008

French-American Biotech & BIO BIZ Symposiums (FABS & FABZ) on “New therapeutical and vaccine approaches in infectious diseases” – April 2nd & 3rd 2008

Apr 12th, 2008 | By French BioBeach | Category: Events News, French BioBeach Events

FABS & FABZ: Two Days of Trans Atlantic BIO Sciences at the interface of Academia & Biotech

The French American Biotech Symposium (FABS), on “New Therapeutical & Vaccine Approaches in Infectious Diseases”, will be held at the Salk Institute in La Jolla next April 2nd 2008.
It will be completed by a business event: French American Bio BIZ Symposium (FABZ) on April 3nd 2008.

French American Biotech Symposium (FABS)

“New Therapeutical and Vaccine approaches in Infectious Diseases”
At the Salk Institute, April 2nd 2008, La Jolla, (CA)

Organized by Lyonbiopole (Rhône-Alpes) and The Office for Science and Technology at the French Consulate in Los Angeles,
In partnership with The Salk Institute for Biological Studies and French Bio Beach, La Jolla
With the presence of Alsace Biovalley (Alsace), Cancer-Bio-Health Cluster (Toulouse), Orpheme (LR-PACA) and Medicen Paris Region
With the support of the French Ministry of Industry (DGE).

Program - Press Kit (PDF)

French American Bio Biz Symposium (FABZ)

“New ways to improve IP portfolio for US-based firms: Internationalization of the French competitiveness clusters”
At the Salk Institute, April 3rd 2008, La Jolla, (CA)

Organized by Lyonbiopole (Rhône-Alpes) and French BioBeach, La Jolla
In partnership with The Office for Science and Technology at the French Consulate in Los Angeles
With the presence of Alsace Biovalley (Alsace), Cancer-Bio-Health Cluster (Toulouse), Orpheme (LR-PACA) and Medicen Paris Region,
With the support of the French Ministry of Industry (DGE).

Program:

8:30 AM – Guest registration
9:00 – 9:05 AM- Welcome Address
9:05 – 9:45 AM – “Introduction to the IP specificities of the French Competitiveness clusters”
- Michael White Ph.D., Sr Licensing Executive, Salk Institute
- Thomas E. Jurgensen Ph.D., CEO, Catalyst Law Group
- Bernard Mandrand Ph.D., CSO, LyonBioPôle
9:45 – 10:20 AM- Testimonials about pending French American programs by San Diego-based firms
- Magda Marquet Ph.D., co-President & co-CEO, Althea Technologies
- Andrew de Guttadauro, VP Corporate Development, Vical
- Drew Hannaman, VP R&D, Ichor Medical Systems
10:20 – 10:45 AM Coffee Break
10:45 -12:30 : Testimonials by French firms about fulfilled programs
- Jean-Baptiste Marchand Ph.D., Head of Immunology, Imaxio
- Sonia Escaich, Ph.D., CEO, Mutabilis
- Maud Bouvier, Scientific and Business Development, ERYtech Pharma
- Nicolas Mouz, Ph.D., CSO, Protein’eXpert
12:30 – 1:00 PM Concluding Remarks : Bernard Mandrand, CSO of LyonBioPôle, will present “how to take part in a French cluster’s program”
1:00 – 2:00 PM Lunch & Networking
2:00 – 5:00 PM One On One B2B session